Market Place
Sourcing Support
Alcon cuts 2024 forecasts, as slow US hits surgical unit
13 Nov 2024 //
REUTERS
Alcon Unveils Precision7, One-Week Replacement Contact Lens
07 Nov 2024 //
BUSINESSWIRE
Alcon Innovations on Display at AAO 2024 Demonstrate Performance
15 Oct 2024 //
BUSINESSWIRE
Alcon Acquires BELKIN Vision for $81M Upfront
01 Jul 2024 //
CONTRACT PHARMA
Alcon Announces Results of 2024 Annual General Meeting
08 May 2024 //
BUSINESSWIRE
Vivity reaches 1 million milestone
02 Apr 2024 //
INDIANPHARMAPOST
Alcon’s Investigational Drops Show Promising Phase III Data in Dry Eye Disease
11 Jan 2024 //
BIOSPACE
Alcon Canada Launches Clareon Vivity
08 Nov 2023 //
BUSINESSWIRE
Alcon Showcases Planning and World-class Digital Technologies During AAO 2023
30 Oct 2023 //
BUSINESSWIRE
Alcon Advances Company’s Social Impact Through Global Volunteerism
22 May 2023 //
BUSINESSWIRE
Alcon Reports First Quarter 2023 Results
09 May 2023 //
BUSINESSWIRE
Alcon Announces Largest-Ever Scientific Presence at ASCRS 2023
01 May 2023 //
BUSINESSWIRE
Alcon to Host 2023 Capital Markets Day
20 Mar 2023 //
BUSINESSWIRE
Alcon takes a new look at ophthalmic pharma space and marketing
13 Mar 2023 //
ENDPTS
Alcon Reports Fourth Quarter and Full Year 2022 Results
27 Feb 2023 //
BUSINESSWIRE
Alcon Prices US$1.3 Billion Senior Notes Offering
29 Nov 2022 //
BUSINESSWIRE
Alcon Completes Acquisition of Aerie Pharmaceuticals
22 Nov 2022 //
BUSINESSWIRE
Sense and R-Biopharm Nederland B.V. Agree to Distribute Rapid
22 Nov 2022 //
BUSINESSWIRE
Alcon Reports Third Quarter 2022 Results
15 Nov 2022 //
BUSINESSWIRE
Alcon Gets PTAB Win In Eye Surgery IP Fight With J&J Unit
07 Nov 2022 //
LAW360
Aerie Pharmaceuticals Reports Third Quarter 2022 Financial Results
03 Nov 2022 //
BUSINESSWIRE
Alcon Sues Padagis to Block Copies of Simbrinza Eye Drops (1)
01 Nov 2022 //
BLOOMBERGLAW
J&J Unit’s Laser Eye Surgery Patent Survives Alcon Challenge
29 Oct 2022 //
BLOOMBERGLAW
Alcon, J&J Vision settle for $75M in contact lens price-fixing case
15 Oct 2022 //
FIERCEBIOTECH
Aerie Pharmaceuticals to Host Key Opinion Leader Event on Dry Eye Disease
13 Sep 2022 //
BUSINESSWIRE
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
22 Aug 2022 //
PRESS RELEASE
Aerie Pharmaceuticals Announces New Employee Inducement Grant
15 Aug 2022 //
BUSINESSWIRE
Alcon Reports Second Quarter 2022 Results
09 Aug 2022 //
BUSINESSWIRE
Aerie Pharmaceuticals Reports Second Quarter 2022 Financial Results
04 Aug 2022 //
BUSINESSWIRE
Aerie Announces 1st Participant Dosed in COMET-3 Study of AR-15512
01 Aug 2022 //
BUSINESSWIRE
Aerie Pharma to Announce Second Quarter 2022 Financial Results
28 Jul 2022 //
BUSINESSWIRE
Kala Pharmaceuticals Completes Sale of EYSUVIS and INVELTYS to Alcon Inc
11 Jul 2022 //
GLOBENEWSWIRE
Aerie Pharmaceuticals Announces New Employee Inducement Grant
08 Jul 2022 //
BUSINESSWIRE
Aerie Pharmaceuticals to Participate in the Jefferies Healthcare Conference
25 May 2022 //
BUSINESSWIRE
Aerie Begins Dosing in PIII Registrational COMET-2 Study of AR-15512
24 May 2022 //
BUSINESSWIRE
Kala buys time by selling eye disease drugs to Alcon for $60M
24 May 2022 //
FIERCEPHARMA
Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop Portfolio
24 May 2022 //
BIOSPACE
Alcon Reports First Quarter 2022 Results
10 May 2022 //
BUSINESSWIRE
Aerie (AERI) Q1 Loss Wider Than Expected, Revenues Rise Y/Y
07 May 2022 //
YAHOO FINANCE
Aerie drops 12% this week, taking three-year losses to 85%
07 May 2022 //
YAHOO FINANCE
Aerie Pharma Reports Q1 2022 Financial Results
05 May 2022 //
BUSINESSWIRE
Aerie Pharma to Announce Q1 2022 Financial Results
28 Apr 2022 //
BUSINESSWIRE
Alcon Announces Results of 2022 Annual General Meeting
27 Apr 2022 //
BUSINESSWIRE
Aerie Pharma Announces Presentations at ASCRS
20 Apr 2022 //
BUSINESSWIRE
Aerie Pharma to Participate in Needham Virtual Conference
06 Apr 2022 //
BUSINESSWIRE
Alcon Publishes Agenda for 2022 Annual General Meeting
23 Mar 2022 //
BUSINESSWIRE
Aerie Pharma Appoints Peter Lang as Chief Financial Officer
18 Mar 2022 //
BUSINESSWIRE
Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio
06 Mar 2022 //
BUSINESSWIRE
Aerie Pharmaceuticals Appoints Gary Sternberg as Chief Medical Officer
24 Feb 2022 //
BUSINESSWIRE
Aerie Pharma Reports Q4 and Full Year 2021 Financial Results
24 Feb 2022 //
BUSINESSWIRE
Aerie Pharmaceuticals to Host Q4 and Full Year 2021 Financial Results on Feb 24
17 Feb 2022 //
BUSINESSWIRE
Alcon Reports Fourth Quarter and Full Year 2021 Results
15 Feb 2022 //
BUSINESSWIRE
Alcon to Launch Systane Complete Preservative-Free Lubricant Eye Drops
12 Jan 2022 //
BUSINESSWIRE
Alcon Launches Systane Complete Preservative-Free Lubricant Eye Drops
11 Jan 2022 //
BUSINESSWIRE
Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Astigmatism
10 Jan 2022 //
BUSINESSWIRE
Aerie Reports Inducement Grant to CEO Under Nasdaq Listing Rule 5635(c)(4)
22 Dec 2021 //
BUSINESSWIRE
Aerie Concludes Exclusive License Agreement With Santen for Rhopressa, Rocklatan
07 Dec 2021 //
PRESS RELEASE
Aerie Announces Positive Phase 3 Topline Results for Netarsudil in Japan
12 Oct 2021 //
BUSINESSWIRE
Alcon launches AcrySof IQ Vivity in India
11 Oct 2021 //
PHARMABIZ
HPO Announces Exclusive Licensing Agreements with Alcon
04 Oct 2021 //
BUSINESSWIRE
